Current role of Immunoscintigraphy in Malignant Melanoma follow-up. A study of 114 patients

Journal of Experimental and Clinical Cancer Research

Volumn 20, Issue 1, 2001, Pages 11-15

  Ribuffo, D ^a   Cavalieri, L ^a   De Vita, F ^a   Massa, R ^a   Prosperi, D ^a   Tuccimei, M ^a   Scuderi, N ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antibodies; Malignant melanoma; Scintigraphy

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; RADIOIMMUNODETECTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SPLENIC NEOPLASMS; TIME FACTORS;

EID: 0035010213     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Clinical demands on radioimmunodetection of melanoma: The importance of prospective trials
2. Imaging with 131 I labelled monoclonal antibodies to a high molecular-weight melanoma associated antigen in patients with melanoma efficacy of whole immunoglobulin and its f(ab′)2 fragments
3. Immunodiagnosis with radiolabelled antimelanoma monoclonal antibodies and F(ab′)2 fragments
4. Imaging of melanoma with 131 I labelled monoclonal antibodies
5. Multicenter study of immunoscintigraphy with radiolabelled monoclonal antibodies in patients with melanoma
6. 99m Tc labelled monoclonal antibodies in tumour scintigraphy. Multicenter studies of the Italian National Research Council
7. Scintigraphy with In - 111 - Labelled monoclonal antitumour antibodies: Kinetics, biodistribution and tumour detection
8. Role of technetium 99m labelled monoclonal antibody in the management of melanoma patients
9. Successful imaging of metastases of malignant melanoma with 99m Tc-glutathione in comparison to 99m Tc- antimelanoma AB: Clinical evaluation
10. Antimelanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma
11. Immunoscintigraphy with 99m Tc - F(ab′) 2 of 225.28S monoclonalantibody in uveal melanoma
12. Role of the radioimmunoscintigraphy and SPECT in the diagnosis of patients with malignant melanoma
13. Immunoscintigraphy in malignant melanoma: A five years clinical experience
14. A radiolabelled iodobenzamide for malignant melanoma staging
15. Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma
16. Enhancement of in vivo monoclonal antibody targeting with recombinat interferon and cytokines
17. Staging of metastatic melanoma by whole-body positron emission tomography (PET) using 2-fluorine-18-fluoro-depxy-glucose (FDG)
18. Malignant melanoma: Staging with whole-body positron emission tomography and (18F) fluorodeoxyglucose
19. Malignant melanomastaging using whole body positron emission tomography
20. Positron emission tomography in the detection and management of metastatic melanoma